Signal active
Bio
Gary Kurtzman has more than 25 years of experience as an entrepreneur, board member, financier and operator. As Managing Director of Healthcare at Safeguard Scientifics (NYSE:SFE), Gary Kurtzman leverages his medical expertise to empower businesses to enhance their products, expand their services, and identify strategic partnership opportunities. Gary Kurtzman has realized value for companies through a series of successful IPOs, M&A and turnaround transactions—most recently Shire’s acquisition of Safeguard’s partner company Advanced BioHealing for $750 million, in cash; and Eli Lilly’s acquisition of Safeguard’s partner company Avid Radiopharmaceuticals for $300 million, up front, with an additional $500 million payout dependent upon the achievement of future regulatory and commercial milestones. Gary Kurtzman’s previous experiences include leadership roles at BioAdvance, Pluvita Corporation, Genovo, Avigen, and Gilead Sciences. Presently, Gary Kurtzman is a lecturer in the Health Care Systems Department at the Wharton School at the University of Pennsylvania where he teaches entrepreneurship in life sciences. In addition, he is also a member of the board at Safeguard’s partner companies Alverix, Crescendo Bioscience, Good Start Genetics, Medivo and PixelOptics.
Location
Wayne, Pennsylvania, United States, North America
Social
Primary Organization
1953
129
74
41
11-50
Financial Services, Venture Capital, Finance, Health Care
Jobs history
0
N/A
Board and Advisor Roles
7
NuvoAir
Chairman of the Board
Invalid date - Current
Moxe Health
Board Member
2016 - Current
Velano Vascular
Board Member
2016 - Current
Zipnosis
Board Member
2017 - Current
meQuilibrium
Board Member
Invalid date - Current
Aktana
Board Member
Invalid date - Current
MedCrypt
Board Chairman
2016 - Current
Invest in regions
Profile Resume
Gary Kurtzman is the Senior Vice President and Managing Director, Healthcare at Safeguard Scientifics, based in United States, North America. With a background in Financial Services, Gary Kurtzman has a rich history of leadership and innovation. Gary Kurtzman studied BS Biology @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
33
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jun 06, 2017 | Trice Medical | Series C - Trice Medical | Safeguard Scientifics | 19.3M |
Nov 14, 2017 | Syapse | Series D - Syapse | Safeguard Scientifics | 30.0M |
Nov 27, 2017 | Prognos Health | Series C - Prognos Health | Safeguard Scientifics | 20.5M |
May 28, 2020 | Syapse | Series F - Syapse | Safeguard Scientifics | 30.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity